Correlation Between Pasithea Therapeutics and Viridian Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and Viridian Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and Viridian Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and Viridian Therapeutics, you can compare the effects of market volatilities on Pasithea Therapeutics and Viridian Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of Viridian Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and Viridian Therapeutics.
Diversification Opportunities for Pasithea Therapeutics and Viridian Therapeutics
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Pasithea and Viridian is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and Viridian Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viridian Therapeutics and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with Viridian Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viridian Therapeutics has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and Viridian Therapeutics go up and down completely randomly.
Pair Corralation between Pasithea Therapeutics and Viridian Therapeutics
Assuming the 90 days horizon Pasithea Therapeutics Corp is expected to generate 36.56 times more return on investment than Viridian Therapeutics. However, Pasithea Therapeutics is 36.56 times more volatile than Viridian Therapeutics. It trades about 0.17 of its potential returns per unit of risk. Viridian Therapeutics is currently generating about 0.01 per unit of risk. If you would invest 3.00 in Pasithea Therapeutics Corp on September 2, 2024 and sell it today you would lose (0.97) from holding Pasithea Therapeutics Corp or give up 32.33% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 52.02% |
| Values | Daily Returns |
Pasithea Therapeutics Corp vs. Viridian Therapeutics
Performance |
| Timeline |
| Pasithea Therapeutics |
| Viridian Therapeutics |
Pasithea Therapeutics and Viridian Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pasithea Therapeutics and Viridian Therapeutics
The main advantage of trading using opposite Pasithea Therapeutics and Viridian Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, Viridian Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viridian Therapeutics will offset losses from the drop in Viridian Therapeutics' long position.| Pasithea Therapeutics vs. Tff Pharmaceuticals | Pasithea Therapeutics vs. Eliem Therapeutics | Pasithea Therapeutics vs. Inhibrx | Pasithea Therapeutics vs. Enliven Therapeutics |
| Viridian Therapeutics vs. Tff Pharmaceuticals | Viridian Therapeutics vs. Eliem Therapeutics | Viridian Therapeutics vs. Inhibrx | Viridian Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |